A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografske podrobnosti
Glavni avtor:	Shehab, Habibul Mohsin
Drugi avtorji:	Yasmin, Hasina
Format:	Thesis
Jezik:	English
Izdano:	Brac University 2024
Teme:	Pharmacovigilance Rivastigmine Alzheimer's disease Dementia Pharmacoepidemiology. Mortality. Alzheimer's disease.
Online dostop:	http://hdl.handle.net/10361/22683

Podobne knjige/članki

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
od: Tabassum, Nadira
Izdano: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
od: Mahee, Sadique Abdal
Izdano: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
od: Alim, Abdul
Izdano: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
od: Karmaker, Swastika
Izdano: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
od: Jahan, Nusrat
Izdano: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
od: Ishrat, Nowshin
Izdano: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
od: Bakar, Osama Bin Abu
Izdano: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
od: Chowdhury, Sariya Uzrat
Izdano: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
od: Islam, Md. Irfath
Izdano: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
od: Saha, Bithi Rani
Izdano: (2023)

Alzheimer's disease and marriage : an intimate account /
od: Wright, Lore K.
Izdano: (1993)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
od: Hassan, Md. Muhtaz
Izdano: (2020)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
od: Tasneem, Sadia
Izdano: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
od: Tamanna, Mst. Taskia
Izdano: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
od: Tasin, Md Abtahi
Izdano: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
od: Aziz, Farhin
Izdano: (2019)

An ambient assisted living system for Alzheimer’s patients
od: Abedin, Minhajul, et al.
Izdano: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
od: Afra, Sumaiya
Izdano: (2022)

Marine compounds in the treatment of Alzheimer’s disease
od: Parveen, Sanjana
Izdano: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
od: Halim, Rabea
Izdano: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
od: Aana, Afsara Sumon
Izdano: (2021)

Exploring Alzheimer's disease prediction with XAI in various neural network models
od: Rahman, Quazi Ashikur, et al.
Izdano: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
od: Mostofa, Golam
Izdano: (2022)

Gene editing for neurodegenerative diseases-A review
od: Sharna, Anika Islam
Izdano: (2023)

A review on adult neurogenesis in Alzheimer’s disease
od: Akter, Moriam
Izdano: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
od: Zaman, Rubaiyat
Izdano: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
od: Haque, Mushfiqul
Izdano: (2019)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
od: Roy, Aditya, et al.
Izdano: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
od: Dey, Manashi
Izdano: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
od: Sani, Mehedi Hasan, et al.
Izdano: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
od: Alam, Badrul, et al.
Izdano: (2016)

Role of circular RNA in neurological disease
od: Salsabil, Labiba
Izdano: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
od: Mahbub, Riasat, et al.
Izdano: (2022)

Skeleton /
od: Parkin, Peter

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
od: Nusrat, Tanzina
Izdano: (2019)

হার্ট, ব্লাড, ফুড /
od: কাসেম, এম এ

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
od: Rahman, Ahadina
Izdano: (2018)

Management of Diabetes patients during COVID-19
od: Pantho, G. M. Golam Mehebub
Izdano: (2021)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
od: Nour, Sabrina
Izdano: (2019)

Detection of alzheimer's disease using deep learning
od: Hasan, Mahmudul, et al.
Izdano: (2021)